Abstract:[Objective] To compare the clinical outcomes of posterior cruciate ligament (PCL) reconstruction by all-inside and conven-tional arthroscopic techniques. [Methods] A retrospective study was performed on 74 patients who underwent arthroscopic PCL reconstruc-tion from July 2016 to July 2021. According to doctor-patient discussion, 31 patients received all-inside PCL reconstruction with autoge-nous semitendinosus tendon graft (the all-inside group), while the other 43 patients underwent conventional arthroscopic PCL reconstruc-tion with allogeneic tendon graft (the routine group). The perioperative, follow-up and imaging data of the two groups were compared. [Results] The all-inside group proved significantly superior to the routine group in terms of total incision length [(7.1±1.3) cm vs (10.3±2.4)cm, P<0.001], the walking time [(3.4±2.1) days vs (5.6±3.2) days, P<0.001], early complication rate (3.2% vs 9.3%, P=0.043) and hospitalstay [(7.4±1.8) days vs (10.3±3.6) days, P<0.001]. In addition, the all-inside group resumed full weight-bearing activities significantly earli-er than the routine group [(93.6±11.7) days vs (128.4±12.4) days, P<0.001]. The VAS score, Lysholm score, IKDC grade, knee flexion-ex-tension ROM, posterior drawer test and backward Lachman test significantly improved in both groups over time (P<0.05). The all-insidegroup was significantly better than the routine group in terms of knees ROM [(124.4±3.6)° vs (116.5±3.2)°, P<0.001; (138.7±3.6)° vs(132.6±5.8)°, P<0.001], Lysholm score [(124.4±3.6) vs (116.5±3.2), P<0.001; (138.7±3.6) vs (132.6±5.8), P<0.001] and IKDC grades 3months postoperatively and at the latest follow-up. Regarding imaging, the all-inside group was also significantly better than the routinegroup in femoral tunnel variation [case, reduced/no change/enlargement, (23/8/0) vs (13/27/3), P<0.001]. [Conclusion] The all-inside ar-throscopic PCL reconstruction is superior in term of clinical consequence to the conventional arthroscopic PCL reconstruction for this liga-ment rupture.